z-logo
open-access-imgOpen Access
Increased Statin Prescribing Does Not Lower Pneumonia Risk
Author(s) -
Linnea A. Polgreen,
Elizabeth Cook,
John M. Brooks,
Yuexin Tang,
Philip M. Polgreen
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ190
Subject(s) - medicine , pneumonia , hydroxymethylglutaryl coa reductase inhibitors , statin , intensive care medicine
Investigators have attributed protective effects of statins against pneumonia and other infections. However, these reports are based on observational data where treatments are not assigned randomly. We aimed to determine if the protective effects of statins against pneumonia are due to nonrandom treatment assignment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom